AChE/BChE/MAO-B-IN-1(Cat No.:I043685)is a multi-target inhibitor designed to simultaneously block the activity of acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and monoamine oxidase B (MAO-B). These enzymes are involved in the breakdown of neurotransmitters like acetylcholine and dopamine, which play crucial roles in cognitive function and neurodegenerative diseases. By inhibiting these enzymes, AChE/BChE/MAO-B-IN-1 may improve neurotransmitter balance, offering potential therapeutic benefits for conditions such as Alzheimer’s disease, Parkinson’s disease, and other age-related cognitive disorders. The compound’s multi-target approach could provide enhanced efficacy compared to single enzyme inhibitors.